Trial Profile
Concomitant and Adjuvant Temozolomide and Radiotherapy for Newly Diagnosed Glioblastoma Multiforme - A Randomized Phase III Study.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 28 Mar 2016
Price :
$35
*
At a glance
- Drugs Temozolomide (Primary)
- Indications Glioblastoma
- Focus Adverse reactions; Therapeutic Use
- 01 May 2009 Results published in the Lancet Oncology.
- 02 Oct 2005 New trial record.